Back to Search Start Over

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Authors :
Uta Oelschlägel
Christian Thiede
Michael Kramer
Martin Bornhäuser
Christoph Röllig
Malte von Bonin
Carsten Müller-Tidow
Gerhard Ehninger
Ioannis Mitroulis
Alwin Krämer
Martin Wermke
Katharina Moll
Source :
Cancer Research. 78:6339-6341
Publication Year :
2018
Publisher :
American Association for Cancer Research (AACR), 2018.

Abstract

Prognosis prediction in patients with acute myeloid leukemia (AML) mainly relies on patient-related factors (e.g., age) and the detection of genomic lesions ([1][1]). De Grandis and colleagues have published that junction adhesion molecule C (JAM-C) is expressed on leukemia-initiating cells (LIC)

Details

ISSN :
15387445 and 00085472
Volume :
78
Database :
OpenAIRE
Journal :
Cancer Research
Accession number :
edsair.doi...........b6e9d76f131567ce0b2800f4969a58a8